110 related articles for article (PubMed ID: 23726228)
1. Imaging and therapy of liver fibrosis using bioreducible polyethylenimine/siRNA complexes conjugated with N-acetylglucosamine as a targeting moiety.
Kim SJ; Ise H; Kim E; Goto M; Akaike T; Chung BH
Biomaterials; 2013 Sep; 34(27):6504-14. PubMed ID: 23726228
[TBL] [Abstract][Full Text] [Related]
2. Desmin- and vimentin-mediated hepatic stellate cell-targeting radiotracer
Zhang D; Zhuang R; Guo Z; Gao M; Huang L; You L; Zhang P; Li J; Su X; Wu H; Chen X; Zhang X
Theranostics; 2018; 8(5):1340-1349. PubMed ID: 29507624
[TBL] [Abstract][Full Text] [Related]
3. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery system based on highly specific recognition of surface-vimentin with N-acetylglucosamine immobilized polyethylenimine.
Kim SJ; Ise H; Goto M; Komura K; Cho CS; Akaike T
Biomaterials; 2011 May; 32(13):3471-80. PubMed ID: 21329974
[TBL] [Abstract][Full Text] [Related]
5. Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier.
Kang JH; Tachibana Y; Kamata W; Mahara A; Harada-Shiba M; Yamaoka T
Bioorg Med Chem; 2010 Jun; 18(11):3946-50. PubMed ID: 20472444
[TBL] [Abstract][Full Text] [Related]
6. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
7. Interactions of vimentin- or desmin-expressing liver cells with N-acetylglucosamine-bearing polymers.
Kim SJ; Ise H; Goto M; Akaike T
Biomaterials; 2012 Mar; 33(7):2154-64. PubMed ID: 22177839
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
9. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X
J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880
[TBL] [Abstract][Full Text] [Related]
10. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Park K; Lee MY; Kim KS; Hahn SK
Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
[TBL] [Abstract][Full Text] [Related]
11. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
12. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis.
Lee H; Kim IK; Park TG
Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095
[TBL] [Abstract][Full Text] [Related]
13. MicroSPECT Imaging-Guided Treatment of Idiopathic Pulmonary Fibrosis in Mice with a Vimentin-Targeting
Zhang D; Zhuang R; Li J; Lv Y; Yang X; Pan W; Zhang X
Mol Pharm; 2021 Nov; 18(11):4140-4147. PubMed ID: 34657437
[TBL] [Abstract][Full Text] [Related]
14. [Silence of VEGFR2 expression mediated by PEI/siRNA complexes].
Yang H; Che O; Chen S; Sun L; Ji AM
Yao Xue Xue Bao; 2010 May; 45(5):576-81. PubMed ID: 20931758
[TBL] [Abstract][Full Text] [Related]
15. N-acetylglucosamine-bearing polymers mimicking O-GlcNAc-modified proteins elicit anti-fibrotic activities in myofibroblasts and activated stellate cells.
Ise H; Araki Y; Song I; Akatsuka G
Glycobiology; 2023 Jan; 33(1):17-37. PubMed ID: 36190502
[TBL] [Abstract][Full Text] [Related]
16. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
17. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
18. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
[TBL] [Abstract][Full Text] [Related]
20. Efficient reduction of serum cholesterol by combining a liver-targeted gene delivery system with chemically modified apolipoprotein B siRNA.
Kang JH; Tachibana Y; Obika S; Harada-Shiba M; Yamaoka T
J Control Release; 2012 Oct; 163(2):119-24. PubMed ID: 22974833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
